|
Hospira, Salesforce.com raised to Buy by Goldman
MarketWatch SAN FRANCISCO (MarketWatch) — Shares of Hospira Inc. (NYSE:HSP) and Salesforce.com Inc. (NYSE:CRM) were raised to a Buy rating by Goldman Sachs on Tuesday. … Goldman Sachs Turns Bullish on salesforce.com, Inc. (CRM), Upgrades to BuyStreetInsider.com (subscription) Salesforce.com: Goldman Upgrades To Buy; Sets $102 TargetBarron’s (blog) Hospira Inc. & Salesforce.com Inc. Raised to Buy at Goldman Sachs; Sapient …Comtex Smartrend BusinessWeek all 16 news articles » |
You must log in to post a comment.